Case Library

Latest case library articles

[EBC] 비후성 심근병증
<figure class="table" style="width:100%;"><table class="ck-table-resized"><colgroup><col style="width:72.4%;"><col style="width:27.6%;"></colgroup><tbody><tr><td><figure class="image"><img style="aspect-ratio:2560/1333;" src="https://upload.wikimedia.org/wikipedia/commons/thumb/4/43/DVA2555_%28CardioNetworks_ECGpedia%29.jpg/2560px-DVA2555_%28CardioNetworks_ECGpedia%29.jpg" alt="undefined" width="2560" height="1333"></figure></td><td><figure class="image"><img style="aspect-ratio:500/1050;" src="/api/download/Vk5UblpMeENJZW5ZVzdEQWtxMGowdWs4ZTd5Z3gvZ3RoRVNjbGpBU0pYVHdTTnB5ZEZBcllKeHRGQysyNE9BWmpuZGJOcXZncTdkQ0JXc2dzSU1HZmc9PQ" width="500" height="1050"></figure></td></tr></tbody></table></figure><p>비후성 심근병증 심전도 예시</p><p> </p><p>Source:</p><p>https://en.wikipedia.org/wiki/Hypertrophic_cardiomyopathy#/media/File:DVA2555_(CardioNetworks_ECGpedia).jpg</p>
Published: 2026-01-31Read more
[EB] 심낭삼출 및 심장눌림증
<figure class="table" style="width:100%;"><table class="ck-table-resized"><colgroup><col style="width:71.63%;"><col style="width:28.37%;"></colgroup><tbody><tr><td><figure class="image"><img style="aspect-ratio:761/600;" src="https://s3.ap-southeast-2.amazonaws.com/wikem.cf.bucket/images/thumb/Pericardial_effusion_with_tamponade.png/761px-Pericardial_effusion_with_tamponade.png?20190402054658" alt="File:Pericardial effusion with tamponade.png" width="761" height="600"></figure></td><td><figure class="image"><img style="aspect-ratio:500/1050;" src="/api/download/Vk5UblpMeENJZW5ZVzdEQWtxMGowcXlYaXAzWG5mNGpNYVcwNlhtdyszSXVkT1dOT2NFVXJZL1VLV0twQUhpUEI0NDJsT1Z6V0liUmhTSklqUnhVWmc9PQ" width="500" height="1050"></figure></td></tr></tbody></table></figure><p>“Critical”과 “PrcEff” 바이오마커가 함께 상승하였습니다. 이것은 심장눌림증 위험도가 높음을 시사합니다.<br> </p><p>ECG Source:</p><p>https://wikem.org/wiki/Pericardial_effusion_and_tamponade</p>
Published: 2026-01-31Read more

[EB] 심낭삼출 및 심장눌림증

Published: 2026-01-31

<figure class="table" style="width:100%;"><table class="ck-table-resized"><colgroup><col style="width:71.63%;"><col style="width:28.37%;"></colgroup><tbody><tr><td><figure class="image"><img style="aspect-ratio:761/600;" src="https://s3.ap-southeast-2.amazonaws.com/wikem.cf.bucket/images/thumb/Pericardial_effusion_with_tamponade.png/761px-Pericardial_effusion_with_tamponade.png?20190402054658" alt="File:Pericardial effusion with tamponade.png" width="761" height="600"></figure></td><td><figure class="image"><img style="aspect-ratio:500/1050;" src="/api/download/Vk5UblpMeENJZW5ZVzdEQWtxMGowcXlYaXAzWG5mNGpNYVcwNlhtdyszSXVkT1dOT2NFVXJZL1VLV0twQUhpUEI0NDJsT1Z6V0liUmhTSklqUnhVWmc9PQ" width="500" height="1050"></figure></td></tr></tbody></table></figure><p>“Critical”과 “PrcEff” 바이오마커가 함께 상승하였습니다. 이것은 심장눌림증 위험도가 높음을 시사합니다.<br> </p><p>ECG Source:</p><p>https://wikem.org/wiki/Pericardial_effusion_and_tamponade</p>